Summary
- Current Price
- As of today, GANX price is $1.68, down -5.08% on
- Current Price All-Time High
- GANX price is currently -90.63% below its historical high of $17.93 set on
- Market Cap
- GANX current market cap is $73M, up +31.65% over the past 365 days
- Revenue
- GANX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for GANX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Gain Therapeutics, Inc. |
| Ticker | NASDAQ: GANX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | gaintherapeutics.com |
| Employees | 23 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.68 | ||
| Price, 1D Change | -5.08% | |
| $73M | ||
| - | ||
| - | ||
| 1.80 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.61 | ||
| EPS, 1Y Change | +31.45% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.61 | ||
| EPS Estimate | -$0.50 | N/A |
| EPS Est. Change | +18.77% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $1.68 | ||
| Price Target | $8.00 | - |
| Price Tgt. Change | +376.19% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.00 | -$0.89 | +11.02% | |
| -$0.65 | -$0.61 | +5.19% | |
| -$0.50 | N/A | +18.77% | |
| -$0.55 | N/A | +10.60% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -7.18% | ||
| -48.78% | ||
| +31.65% | ||
| +76.96% | ||
| 0.00% | ||
| -100.00% | ||
| +31.45% | ||
| +58.69% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.68 | ||
| $2.05 | ||
| $1.84 | ||
| $1.95 | ||
| $1.82 | ||
| -$0.02 | ||
| 1.80 | ||
| $0.10 | ||
| 40.55 | ||
| 62.31% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.61 | ||
| $0.00 | ||
| - | ||
| -$18.71M | ||
| - | ||
| -$20.16M | ||
| - | ||
| -$18.62M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.04 | ||
| 6.63 | ||
| 6.63 | ||
| - | ||
| - | ||
| 2.41 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 6.49 | ||
| -3.17 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $18.56M | ||
| $20.84M | ||
| $22.82M | ||
| $22.24M | ||
| $4.25M | ||
| $3.35M | ||
| $732.10K | ||
| $220.70K | ||
| $825.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $20.16M | ||
| $18.71M | ||
| $94.00K | ||
| $0.00 | ||
| $94.00K | ||
| $0.00 | ||
| $861.10K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$18.47M | ||
| $0.00 | ||
| $28.45M | ||
| $0.00 | ||
| -$18.47M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | → | |
| BTIG | → | |
| Roth Capital | → |
Analyst sentiment
Institutional ownership
Screeners with GANX
FAQ
- What is the ticker symbol for Gain Therapeutics, Inc.?
- The ticker symbol for Gain Therapeutics, Inc. is NASDAQ:GANX
- Does Gain Therapeutics, Inc. pay dividends?
- No, Gain Therapeutics, Inc. does not pay dividends
- What sector is Gain Therapeutics, Inc. in?
- Gain Therapeutics, Inc. is in the Healthcare sector
- What industry is Gain Therapeutics, Inc. in?
- Gain Therapeutics, Inc. is in the Biotechnology industry
- What country is Gain Therapeutics, Inc. based in?
- Gain Therapeutics, Inc. is headquartered in United States
- When did Gain Therapeutics, Inc. go public?
- Gain Therapeutics, Inc. initial public offering (IPO) was on March 19, 2021
- Is Gain Therapeutics, Inc. in the S&P 500?
- No, Gain Therapeutics, Inc. is not included in the S&P 500 index
- Is Gain Therapeutics, Inc. in the NASDAQ 100?
- No, Gain Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Gain Therapeutics, Inc. in the Dow Jones?
- No, Gain Therapeutics, Inc. is not included in the Dow Jones index
- When was Gain Therapeutics, Inc. last earnings report?
- Gain Therapeutics, Inc.'s most recent earnings report was on March 25, 2025
- When does Gain Therapeutics, Inc. report earnings?
- The date for Gain Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- GANX Official Website gaintherapeutics.com
- GANX Profile on Yahoo Finance finance.yahoo.com/quote/GANX
- GANX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ganx